IMMX · Forms 3, 4, 5
Insider trades at Immix Biopharma, Inc.
No open-market insider buys or sells at Immix Biopharma, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Immix Biopharma, Inc. (IMMX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Immix Biopharma, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gabriel S Morris | CFO, President | Options or other derivatives | Form 4 | ||||
| Ilya M Rachman | CEO and Chairman | Options or other derivatives | Form 4 | ||||
| Helen C. Adams | Director | Award | 6,250 | Form 4 | |||
| Carey Ng | Director | Award | 6,250 | Form 4 | |||
| Magda Marquet | Director | Award | 6,250 | Form 4 | |||
| Nancy T Chang | Director | Award | 6,250 | Form 4 | |||
| Yekaterina Chudnovsky | Director | Award | 6,250 | Form 4 | |||
| Jason Hsu | Director | Award | 6,250 | Form 4 | |||
| Jane Buchan | Director | Award | 6,250 | Form 4 | |||
| Nancy T Chang | Director | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.